LEHVOSS Personal Care has announced a new strategic partnership with Shenzhen Dieckmann Biotechnology Co., LTD. This partnership will introduce innovative, high-performance ceramide ingredients to key personal care markets across Europe, advancing product formulations that support skin health and wellness. Ceramides play a critical role in maintaining the skin’s barrier function, strengthening the stratum corneum, and protecting against external aggressors.
Through this collaboration, LEHVOSS Personal Care will now offer two of Dieckmann's ceramide products in the European market:
- 3CER, CERAMIDE NP: This product offers benefits such as barrier repair, moisturizing, and anti-inflammatory properties.
- DKM PHS, PHYTOSPHINGOSINE: This product is designed for smoothing, moisturizing, anti-inflammatory effects.
Commenting on the partnership, Dr. Michael Lütke, Global Director of LEHVOSS Personal Care, said, “We are thrilled to collaborate with Shenzhen Dieckmann Biotechnology, their cutting-edge ceramides align perfectly with our mission to bring the most advanced, effective, and sustainable ingredients to the personal care market. We look forward to launching 2nd and 3rd generation ceramides and derivatives soon, in close alignment with our customer needs.”
This strategic partnership is also a crucial step for Shenzhen Dickman Biotechnology Co., Ltd to lay out its global market, according to Mr. Yang Chaowen, general manager of Dieckmann. "We are delighted to be partner with a century-old enterprise like LEHVOSS. Dieckmann has won widespread recognition and praise in the market with its high-quality products and technology innovation over the years. In the future, Dieckmann will establish a solid strategic partnership with LEHVOSS to continue providing high-quality products and services to global customers, bringing green, natural, and innovative ceramides to the global market.”
About Shenzhen Dieckmann Biotechnology Co., LTD
Shenzhen Dieckmann Biotechnology Co., LTD is a high-tech enterprise specializing in the R&D and production of functional small molecular components for the personal care industry，has applied for 50 patents. Utilizing modern synthesis, extraction, and enzymatic catalysis technologies, the company is committed to offering innovative and sustainable solutions for the global market.